pharma · Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · metastatic or unresectable, recurrent HNSCC
Createrna Science and
Wuhan Createrna Science and Technology Co., Ltd
Createrna Science and patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- shanghai, CN, London
- Employees
- 26
- Programs
- 51
- Drugs
- 87
- Patents
- 0
Createrna Science and patents
0 pharmaceutical patents indexed for Createrna Science and. 0 expire within 24 months.
Createrna Science and has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Createrna Science and have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Createrna Science and patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.